Eloxx Pharmaceuticals

$2.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.17%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ELOX and other stocks, options, and ETFs commission-free!

About ELOX

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Read More It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA. The listed name for ELOX is Eloxx Pharmaceuticals, Inc. Common Stock.

CEO
Gregory C. Williams
Employees
29
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
101.55M
Price-Earnings Ratio
Dividend Yield
Average Volume
36.19K
High Today
$2.61
Low Today
$2.50
Open Price
$2.56
Volume
38.12K
52 Week High
$8.16
52 Week Low
$1.44

Collections

ELOX Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Nov 5, After Hours

You May Also Like